NEW YORK—Porter Novelli has hired Joseph Landi as executive vice president and director of New York healthcare and Shipra Singh as the head of health care for Europe, the Middle East and Asia. At the same time, Peter Pitts has been appointed to the new post of global head of regulatory and health policy, reflecting the growing need for client counsel in this area beyond the traditional pharmaceutical sector.
Landi will direct the largest healthcare team in the agency and be accountable for client and staff development. He joins Porter Novelli from Landmark Communications, which he founded in 1995. As president of Landmark, he managed high-profile public relations campaigns, including pre-launch scientific communications for pain-reliever Celebrex and multiple-sclerosis treatment Rebif; an eight-year brand-awareness campaign for sleep medication Ambien®; and the launches of Ultracet for chronic pain and Cardizem LA for hypertension.
Prior to founding Landmark, he worked for several agencies including Wang Associates, Grey Healthcare Group, Burson-Marsteller and Edelman. He reports to Lisa Rosenberg, partner and managing director of Porter Novelli’s New York office.
In his new role, Singh will coordinate the international delivery of healthcare programs, ensure exceptional client service and continue the agency’s expansion in pharmaceutical marketing, medical education and consumer health and well-being. Prior to joining Porter Novelli, Singh was head of strategic services for Hill & Knowlton and previously was the managing director of Bell Pottinger’s health group
Pitts will advise on agency work in food, personal care, packaged goods and any other sector in which a global perspective on regulatory and health policy can impact business outcomes. He will continue to report to Julie Winskie, Porter Novelli’s president, global clients.